Amy G. Wong

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

Andisheh Abedini, Annette Plesner, Ping Cao et al. · eLife · 2016 · 161 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin

Rebekah L. Bower, Lauren R. Yule, Tayla A. Rees et al. · ACS Pharmacology & Translational Science · 2018 · 80 citations · Full text

Medicine, Endocrinology, Pharmacology +17

The contribution of the endogenous <scp>TRPV1</scp> ligands 9‐<scp>HODE</scp> and 13‐<scp>HODE</scp> to nociceptive processing and their role in peripheral inflammatory pain mechanisms

Mohammad Alsalem, Amy G. Wong, P Millns et al. · British Journal of Pharmacology · 2012 · 63 citations · Full text

Life Sciences, Neurobiology, Pharmacology +17

Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions

Ling‐Hsien Tu, Lydia Young, Amy G. Wong et al. · Biochemistry · 2014 · 60 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Analysis of the Amyloidogenic Potential of Pufferfish (<i>Takifugu rubripes</i>) Islet Amyloid Polypeptide Highlights the Limitations of Thioflavin-T Assays and the Difficulties in Defining Amyloidogenicity

Amy G. Wong, Chun Wu, Eleni Hannaberry et al. · Biochemistry · 2015 · 60 citations

Life Sciences, Biochemistry, Endocrinology +7